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Abstract
Background: A new implementation has been made on CloudMC, a cloud-based platform presented in a previous
work, in order to provide services for radiotherapy treatment verification by means of Monte Carlo in a fast, easy
and economical way. A description of the architecture of the application and the new developments implemented
is presented together with the results of the tests carried out to validate its performance.
Methods: CloudMC has been developed over Microsoft Azure cloud. It is based on a map/reduce implementation
for Monte Carlo calculations distribution over a dynamic cluster of virtual machines in order to reduce calculation
time. CloudMC has been updated with new methods to read and process the information related to radiotherapy
treatment verification: CT image set, treatment plan, structures and dose distribution files in DICOM format. Some
tests have been designed in order to determine, for the different tasks, the most suitable type of virtual machines
from those available in Azure. Finally, the performance of Monte Carlo verification in CloudMC is studied through
three real cases that involve different treatment techniques, linac models and Monte Carlo codes.
Results: Considering computational and economic factors, D1_v2 and G1 virtual machines were selected as the
default type for the Worker Roles and the Reducer Role respectively. Calculation times up to 33 min and costs of 16 €
were achieved for the verification cases presented when a statistical uncertainty below 2% (2σ) was required. The costs
were reduced to 3–6 € when uncertainty requirements are relaxed to 4%.
Conclusions: Advantages like high computational power, scalability, easy access and pay-per-usage model, make
Monte Carlo cloud-based solutions, like the one presented in this work, an important step forward to solve the long-
lived problem of truly introducing the Monte Carlo algorithms in the daily routine of the radiotherapy planning process.
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Background
Monte Carlo (MC) simulations have become the gold
standard for dose calculation in radiation therapy treat-
ments since they include the real physical processes in-
volved in the interaction of photons with matter in
general and human tissues in particular [1, 2]. Some of
the codes most frequently used in the radiation therapy
field are, for example, EGSnrc [3], MCNP [4], PENEL-
OPE [5] or GEANT4 [6]. Making use of the named
codes, some friendly-user software is often developed.
For example, for PENELOPE code, PenEasy, a
general-purpose main program [7], and PRIMO, an ap-
plication for clinical linacs MC calculations with graph-
ical user interface included [8], are available.
Regardless of the code used, a huge number of
simulated particles is necessary to achieve a precise
solution because of the stochastic nature of the MC
approach. Therefore, these simulations are often
computationally-expensive or time-consuming [9]. A pos-
sible approach to handle this is the use of cluster-based
parallel computing for speeding up MC simulations [10].
The main barrier to this solution is the high investment
needed, as well as associated maintenance, upgrade and
staff costs [11]. Such costs make practically unfeasible the
use of MC simulations in a routine clinical basis.
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Another proposed way to address the MC computa-
tional cost is the use of the graphics processing unit
(GPU), whose architecture seems suitable for parallel
computations since it comprises thousands of processing
units on a single chip [12–14]. However, the size of the
memory of this kind of devices is very limited compared
to CPU-based implementations. This, together with
other issues, makes their performance worse than what
it could be expected as it was shown in a recently pub-
lished point-counterpoint [15].
A more economically efficient approach is the use of
the Cloud, which essentially consists of a set of com-
puting resources offered through internet as a
pay-per-usage service [16]. In a Cloud Computing en-
vironment it is easy to create a virtual cluster with the
capability of distributing any tasks onto the multiple
computing nodes, which makes parallel computation
available. Using such an approach, there is no need for
initial investment since the facilities are already built
and their maintenance is assumed by the owning com-
panies. Instead, the whole outlay is about the costs of
the resources actually used. Furthermore, applications
can be scalable, so their computational resources can
change at runtime to match the real needs, while the
capacity of a conventional cluster is fixed, so the effi-
ciency might not be optimal [17]. The likelihood of fu-
ture implementation of the Cloud Computing paradigm
in the routine of clinical radiation therapy has been
highlighted [18].
In a previous work [19], we presented CloudMC, a
cloud-based platform developed over Microsoft Azure®
cloud. It was originally intended to provide computa-
tional power to run MC simulations in a short time.
This is accomplished through the distribution of the
calculations over a dynamic cluster of virtual machines
(VMs) that are provisioned on demand and removed
automatically once the simulation is finished.
CloudMC was designed following some basic
premises:
– Accessibility: As CloudMC is presented as a web
application, it is accessible to any user through
internet, without the need of installing any software
or acquiring any hardware.
– Multi-application: It is possible to run different MC
programs independently on the MC code in which
they are based on.
– Non-intrusiveness: There is no need of modifying
the code or the MC programs in order to be
executed on this platform.
– Elasticity: The computational resources are not
fixed, the user is able to select the number of
computational nodes in which the calculations will
be distributed.
During the last years, new developments have been
implemented on CloudMC to include the service of MC
verification of radiotherapy (RT) treatments and to im-
prove its efficiency. This developments are presented in
this work, together with a study of the performance of
CloudMC for MC verification service.
Methods
CloudMC
CloudMC architecture is shown in Fig. 1. From the soft-
ware architectural point of view, CloudMC follows a
classical n-layered architecture, making wide use of de-
pendency injection across the different layers in order to
loose coupling. This means that the software is com-
posed by several autonomous modules, allowing an eas-
ier testing and evolution of the whole system.
The first layer is the user interface, which in CloudMC
is a web application. As such, it only requires a web
browser to be used. It is based on a Microsoft web
framework called Microsoft ASP.Net MVC 4. It follows,
therefore, a model view controller architecture, a widely
used pattern in the development of software user inter-
faces that break down them in three components:
model, view and controller. In CloudMC, views are
mainly HTML pages with some Razor [20] components
and Javascript utilities to improve interactivity and user
experience. Controllers are C# [21] (a type-safe
object-oriented programming language) classes support-
ing, mainly, typical CRUD operations (Create, Read,
Update and Delete) for the entities CloudMC manages.
On the center of this architecture, there is an Entities
layer [22], where key domain concepts are defined as
plain C# classes. Figure 2 is a diagram of the three main
entities and their dependencies. The main concept is the
MC Model entity, which represents a group of files that
can run a MC simulation. Associated to this MC Model,
there are several entities that represent the configuration
of how to run this MC Model in parallel. Basically, they
determine the files and the position, inside of these files,
where the input parameters (number of histories, execu-
tion time or random seeds and the mobile geometric el-
ements) that have to be modified are located as well as
the contents of the output files and their formats.
The second important entity is the RT Case. This en-
tity contains the set of patient specific files that define a
RT treatment and an instance of the MC Model that will
be used to perform the MC calculations.
The third important entity is the Simulation. A Simula-
tion can represent an execution of either a MC Model or a
RT Case. A Simulation is also configured with the number
of execution nodes that will be used for the parallelization,
and with other parameters like number of histories to
simulate. Simulation has a state (Inactive, downloading
files, simulating, uploading results and finished) and, in
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case it is finished, a list of output results and an
evaluation.
The following layer is Services. It contains several C#
services that coordinates all the steps to create a simula-
tion, to run it in parallel on the computation nodes, and
to collect the results once the simulation is finished.
Services layer uses the MapReduce module to configure
MC Model files for parallelization, based on MC Model
instance configuration. MapReduce module contains the
cornerstone of the logic of CloudMC, which allows to
achieve the parallel execution of different types of Monte
Carlo applications (map) and merge their results (reduce).
Furthermore, Services layer uses the Provisioning mod-
ule to create the compute nodes that will run the simu-
lation. Currently, CloudMC relies on Microsoft Azure.
Thus, the Provisioning module communicates with
Azure Services Management REST API, a Microsoft
Azure interface that relies on HTTP protocol which al-
lows other software systems to consume its services, to
request the creation/deletion of the compute nodes.
Finally, the Repositories layer handles the persistence
of the entities and assets of CloudMC. Two types of per-
sistency technologies are used; on one hand, there is a
document database [23], specifically MongoDB, that
stores entities metadata. On the other hand, all the files
corresponding to MC Model, RT Case and Simulation
are stored in Microsoft Azure Storage, a cloud object
storage for unstructured data.
The new features added to this version of CloudMC are:
○ Implementation of Evil-DICOM library [24], a C# class
library for reading and manipulating DICOM files [25].
○ PlanRT class for reading RT plans in DICOM
format exported from a treatment planning system
(TPS). It contains methods to transform different
Fig. 2 Representation of the main CloudMC entities
Fig. 1 CloudMC architecture
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types of dynamic beams into a discrete set of static
beams that can be calculated by MC simulation.
○ CTimage class for reading the patient CT image set
and convert it to PENELOPE (PenVox) or EGS
(egsphan) voxelized geometries from a HU / density-
material conversion table defined by the user. This
conversion has also the possibility to change the size
and resolution of the voxelized phantom.
○ RTDose class. It allows to read, modify and write
dose distribution files in DICOM format (RTDOSE).
The final dose distribution of the MC verification is
transformed into this format to facilitate the
evaluation with other programs.
○ PlanEval is a set of classes that makes it possible to
read dose matrix and structure files in DICOM
format (RTDOSE and RTSTRUCT) for treatment
evaluation purposes. For instance, calculating dose-
volume histograms (DVH).
○ Geometry Mapper is a set of methods that are used
to manage the information related to mobile
geometric elements (isocenter shifts, gantry,
collimator and table angles, MLC and jaws
positions, etc.) contained in the MC input files.
These files are modified for each verification case
with the information read from the corresponding
DICOM RT plan. It also has a method to distribute
the calculations of the treatment beams over the
available computing nodes. Two options are
implemented: “Equal” and “MUWeighted”. With the
“Equal” option the different beams are distributed in
the same number of computing nodes, while with
the “MUWeighted” option the beams are distributed
in a number of nodes proportional to their weight
in terms of relative MU.
○ Reducing binary outputs. In the first versions of
CloudMC, the output could only be managed if it
was a text file with data in column format. A
parametrization for reducing general binary files has
been implemented. These files are supposed to have
a header, which will not be modified in the reducing
process, and the dose distribution data followed by
the corresponding uncertainty distribution in single
or double precision format.
Azure roles tests
In Azure, a Cloud Service Role is a collection of man-
aged, load-balanced, Platform-as-a-Service VMs that
work together to perform common tasks. There are two
varieties: Web Role and Worker Role. A Web Role is a
Cloud Service role where web applications are imple-
mented. These applications contain the user interface
through which the user interacts with and are developed
through programming languages / technologies that are
supported by Internet Information Services (IIS), such as
ASP.NET, PHP, Windows Communication Foundation
and Fast CGI. A Worker Role is any VM in Azure that
runs applications and services level tasks. They are
mainly used to perform supporting background pro-
cesses along with Web Roles. Worker Roles can only be
developed with .NET.
The VMs that support Azure roles can be of different
types and sizes [26]. VMs are classified in several series.
The ones considered in this work are described below.
 A-series: General purpose VMs. Can be deployed on
various types of hardware and processors. They were
the only type of machines eligible during the early
times of Azure.
 D-series: Optimized compute. D-series VMs are
designed to run applications that demand higher com-
pute power and temporary disk performance. D-series
VMs feature a solid-state drive (SSD), faster proces-
sors and a higher memory-to-core ratio than A-series.
 Dv2 and Dv3-series: Next generation of D-series.
Their CPU is about 35% faster than the D-series
CPU. They are based on the latest generation
2.4 GHz Intel Xeon® E5–2673 v3 (Haswell) proces-
sor and with Intel Turbo Boost Technology 2.0 that
can go up to 3.2 GHz.
 Ev3-series: Memory intensive VMs. Running on the
Intel® Broadwell E5–2673 v4 2.3GHz processor, and
the Intel® Haswell 2.4 GHz E5–2673 v3.
 G-series: Memory optimized and high memory-to-
core ratio VMs that feature Intel® Xeon® processor
E5 v3 family.
Inside each series, it is possible to choose between sev-
eral sizes of VMs, i.e. different amount of cores, RAM,
temporary storage, etc. The price-per-hour of a VM de-
pends on its type and size.
Some tests were conducted in order to determine the
most suitable type and size for the set of Worker Roles
that run the MC simulations in CloudMC and for the
role responsible for the reducing tasks, the so called Re-
ducer Role in this paper. For performance benchmarking
of the different types and sizes of Worker Roles, a
PenEasy [7] execution corresponding to a 3·105 histories
MC simulation of an iodine radioactive seed in a COMS
ophthalmic applicator [27] has been run on a single ma-
chine of different type/size each time. The tally files
resulting from the PenEasy simulations contain the in-
formation of the spent CPU time, which will be used to
evaluate the efficiency of the different VM types in exe-
cuting this task.
The test for the Reducer Role consisted in the execu-
tion of a MC simulation of a radiotherapy beam on a pa-
tient phantom in 500 Worker Roles. Then, different
types of VMs were used to perform the reduce tasks of
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the output files generated by the Worker Roles. Each
Worker Role produces two output files, a 12 MB binary
dose distribution file and an 8 MB IAEA PHSP. The
time spent on the reduce task and on uploading the final
results to the storage for each Reducer type was
evaluated.
MC treatment verification in CloudMC
In order to show the performance of the MC treatment
verification process on CloudMC, three different cases
have been selected corresponding to three different
treatments in three different LINAC models and involv-
ing the use of three different MC codes. The aim of con-
sidering so many variables was to prove that the
conclusions are applicable to a wide range of cases. All
these cases have the same structure in common. The
calculations start from a source phase space file (PHSP),
in IAEA format [28], previously calculated at the plane
just before the beam modifiers (jaws and MLC). This
source PHSP is used by the MC program that contains
the MC model of the linac to generate the secondary
PHSPs at the end of the beam modifiers. Finally, these
secondary PHSPs are used as source by PenEasy to ob-
tain the dose distribution inside a voxelized geometry
built from the CT image set of the patient.
The previous calculation of the source PHSPs has also
been performed with CloudMC using the corresponding
MC Model for each linac. The generated PHSPs contain
more than 5·108 particles and are larger than 15 GB.
Case 1: mArc H&N treatment planned for a Siemens
ONCOR® LINAC with the 160-MLC multi-leaf collima-
tor. The MC model uses an in-house developed program
[29] based on the Geant4 code [6, 30, 31]. The mArc
[32, 33] technique is the approach to volumetric therapy
proposed by Siemens. It consists in a rotational beam di-
vided in small arclets (of 2–4 degrees width), which in
our case are 8 degrees apart from each other. While the
gantry rotates, the beam is switched on only when the
angle position is within the arclets. From the end of one
arclet to the beginning of the next one the beam is
switched off and the MLC moves to reach the next con-
trol point configuration. CloudMC reads the DICOM
RT plan and transforms each arclet to a static beam with
a gantry angle equal to the arclet central angle and the
same MU delivered during the arclet. The voxelized
phantom generated had a 2x2x5 mm3 resolution.
Case 2: Static IMRT prostate treatment planned for a
Siemens PRIMUS® linac. The MC model used for this
linac was developed by Leal et al. [34, 35] using the pro-
gram BEAMnrc [36], based on the EGSnrc code [3]. The
treatment consists of 25 control points distributed in
seven incidences. The calculation voxel size was also
2x2x5 mm3.
Case 3: SBRT lung treatment planned for a Varian
Clinac 2300® with 120-MLC. The back-end programs of
PRIMO software [8], version 0.1.5.1307, were used for
MC calculations (PenEasyLinac.exe and PenEasy_PRI-
MO.exe). The treatment consists of nine static beams
conformed to the planning target volume (PTV). A
smaller voxel size of 2.5 × 2.5 × 2 mm3 was used to
match, like in cases 1 and 2, the same calculation grid
resolution used in the TPS.
From these three RT cases, several simulations have
been run changing the number of histories and the num-
ber of Worker Roles to study the feasibility of CloudMC
to perform MC verification of RT treatments. The VM
type chosen for the Worker Roles was the D1_v2, while a
G1 VM was used for Reducer Role. For each case, two
simulations were run using different number of histories
in order to obtain results with two levels of uncertainty,
one below 4% and another below 2% (2σ).
PRIMO implementation in CloudMC
The PRIMO implementation in CloudMC has a special
interest, because it allows to simulate in CloudMC all
the LINACS modelled in the PRIMO software. In order
to understand how it was implemented, we first need to
present a brief explanation of PRIMO software. PRIMO
is a MC platform that allows for the simulation of a wide
variety of Varian and Elekta linacs. It makes use of the
physics from PENELOPE code through the main simula-
tion program PenEasy [7]. Dedicated variance reduction
techniques have been implemented to reduce computa-
tion times. The main program PRIMO.exe contains the
graphical interface through which the user configures
the simulation as well as analyze the results. This pro-
gram is also responsible for managing the back-end pro-
grams preparing their input, controlling the execution
and collecting as well as presenting their results. These
programs are PenEasy_PRIMO and PenEasyLinac.
PenEasy_PRIMO is a dedicated version of the PenEasy
code, while PenEasyLinac is a program that prepares the
linac geometry and the input files for PenEasy.
When a PRIMO user launches a simulation, PRIMO
transcribes the information defined by the user through
the graphical interface into input text files for PenEasyLi-
nac. Then PRIMO calls the execution of PenEasyLinac,
which generates the input files for PenEasy_PRIMO.
These input files consist of a main PenEasy input file, the
material files and the linac geometry modified with the
user defined beam configuration. PRIMO calls then the
execution of PenEasy_PRIMO that carries out the MC
simulation and manages the map/reduce tasks if the user
had selected the parallelization in several cores.
PRIMO cannot be implemented as it is in CloudMC
because CloudMC only works with programs that have
text files as input and this is not the case of PRIMO.
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However, it is actually the case of its back-end programs.
Subsequently, to create the MC model of PRIMO in
CloudMC the input files of PenEasyLinac are parame-
trized for the map tasks. The file PenEasyLinPlus.in con-
tains the information about the number of histories and
the initial random seeds while the file PRIMOPEL.in
contains the linac model name and the geometric con-
figuration of the beam. The files required to create the
MC model in CloudMC are mainly the ones contained
in the PenEasyLinac folder, so this folder was uploaded
completely into the corresponding container in the
Azure Storage system.
Once this MC model of PRIMO is created in
CloudMC it is possible to use all the features of the plat-
form like performing MC verification of all sort of RT
treatments calculated for any of the linac models con-
tained in PRIMO.
Results
Virtual machine type tests
The results of the Worker and Reducer Roles perform-
ance tests in the different types of VMs are shown in
Table 1. Information about the VMs specifications is also
provided [26]. The outcome considered for the Worker
Role test was the CPU time spent on the execution of
the PenEasy MC program. CPU times are also presented
relative to the A1 (Small) size (Rel. Time column in
Table 1). The fastest machine was found to be the G1,
but it is also the most expensive. It can be seen that the
number of cores is not a factor to take into account for
the calculation speed. The most influencing factor is the
processor features. As it was previously explained,
D-series are compute-optimized machines with faster
processors than the A-series. Furthermore, Dv2-series
are even faster, as they are based on the latest generation
2.4 GHz Intel Xeon® E5–2673 v3 (Haswell) processor.
The “cost-efficiency” factor, presented in the 8th col-
umn of Table 1, is calculated as the product of the time
and the cost relative to the A1 machine. The VM type
with best cost-efficiency is the D1_v2; this means that a
simulation executed on this machine will cost less than
the same simulation executed on any other of the ma-
chines analyzed.
To evaluate the performance of different types of VMs
for the reduce tasks, the time spent by the Reducer Role
on merging the simulation output files and uploading
the final results to the Storage are presented in the lasts
columns of Table 1. Two output files per Worker Role
were generated in each simulation, an 8 MB IAEA phase
space and a 12 MB dose distribution in binary format.
Since the number of Worker Roles was set to 500, it
means that the Reducer Role has to download and
process 1000 files corresponding to 9.4 GB of data. The
size of the reduced files that are finally uploaded to the
storage is 3.77 GB. The time that the Reducer Role
spends downloading the results of the Workers from the
Storage is not considered. That is because the Reducer is
already alive when the Workers are running the simula-
tion and it is downloading the results in real time as the
Workers are finishing.
VM types with high RAM have a similar performance
for the reduce tasks. In order to choose one type as
Table 1 Characteristics of the different VM types and sizes (columns 2–5) and results of the execution speed test (columns 6–8) and
the reducer test (columns 9 and 10)
VM type CPU cores RAM (GB) Disk (GB) Cost (€/h) CPU time (min) Rel. Time Cost. Eff. Merging time (min) Upload time (min)
Small (A1) 1 1.75 225 0.0675 11.30 1.00 1.00 18.9 6.7
Medium (A2) 2 3.5 490 0.135 11.60 1.03 2.05 15.4 6.7
Large (A3) 4 7 1000 0.2699 11.87 1.05 4.20 11.5 6.7
D1 1 3.5 50 0.1249 7.32 0.65 1.20 19.8 5.2
D1_v2 1 3.5 50 0.1249 5.47 0.48 0.90 18.1 7.0
D2_v2 2 7 100 0.2505 5.08 0.45 1.67 8.3 7.0
D2_v3 2 8 16 0.1788 5.65 0.50 1.32 11.2 6.3
D3_v2 4 14 200 0.5001 5.48 0.48 3.59 3.6 6.4
D4_v2 8 28 400 1.001 5.09 0.45 6.68 3.9 4.0
D11 2 14 100 0.291 7.58 0.67 2.89 6.1 5.3
D11_v2 2 14 100 0.291 5.53 0.49 2.11 4.3 5.6
E2_v3 2 16 32 0.2126 5.65 0.50 1.57 4.1 5.5
E4_v3 4 32 64 0.4251 5.70 0.50 3.18 4.0 4.0
G1 2 28 384 0.6496 262 0.39 3.72 3.4 3.9
G2 4 56 768 1.2987 293 0.43 8.31 3.3 3.6
Most optimal cost-efficiency value highlighted in bold
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default, other features, like the disk capacity and the
cost, need to be taken into account. For example,
E-series machines have a good performance, but they
have less disk capacity, which may not be enough for
some simulations involving very large PHSPs. According
to all this, G1 has been chosen as the preferred VM for
the Reducer Role.
MC verification cases
The results of the performance of three MC verification
cases in CloudMC are presented in Table 2. For each
case, two simulations were run. Simulation 1 produces a
dose distribution with a 2σ uncertainty of around 4% in
the PTV, while for simulation 2, a four times higher
number of histories was selected to obtain a lower un-
certainty, below 2% in the PTV. The Workers mean time
is given with its associated standard deviation. The total
simulation time reported corresponds to the interval
since the user clicks the run button until the Reducer up-
loads the final results to the Storage. It includes the time
needed to mount the Workers and Reducer cloud ser-
vices, the start-up time (SUT) of the VMs, the execution
tasks performed by the Workers and the processing tasks
performed by the Reducer. The time required to upload
the patient data to the application was not considered.
From the two values of Workers mean time obtained
for each case it is possible to estimate the
non-parallelizable time. Non-parallelizable tasks are the
ones that cannot be divided and, therefore, have to be
done in all the Worker Roles: downloading files from
the storage, initializing the MC programs, processing
output files and uploading results to Storage. The
non-parallelizable time is the main factor responsible for
the increase in the cost when more compute nodes are
used for parallelization. This time was estimated in 1.5,
1.6 and 3.9 min for the three cases presented respect-
ively. The main reason for case 3 having larger
non-parallelizable time is the smaller voxel size used.
The CT data set is also larger than the ones in case 1
and 2 because the scan covers a larger anatomical re-
gion. This requires the manipulation of large files during
all the simulation process and, consequently, it results in
an increase of the time of the non-parallelizable tasks.
This is also the reason for the larger merging times in
the reducer phase.
Discussion
The calculation speed is not the only feature to consider
when choosing the most adequate VM type because the
calculation times are reduced in CloudMC mainly by
means of the parallelization strategy. The cost per hour
is another important factor. The VM with best cost effi-
ciency was shown to be the D1_v2 and, for this reason,
it was the default type chosen for the Worker Roles in
CloudMC.
When it comes to choosing the VM as the Reducer
Role, its cost is not such an important factor because it
will only contribute to a small proportion of the total
cost of the simulation. The cost of a simulation is calcu-
lated from the usage time of every VM (Web Role,
Worker Roles and Reduccer Role) and their cost per
hour. Therefore, the main contribution to the simulation
cost will come from the Worker Roles when a large
number of them is selected. For all these reasons, having
short reducing times was prioritized and the G1 is the
default size for the Reducer Role in CloudMC.
One of the steps that increases the most the time of a
simulation in CloudMC is the Worker Roles SUT. When
Table 2 Performance results of three different MC verification cases in CloudMC. For each case, the results of two simulations with
different number of histories are presented
Case 1 Case 2 Case 3
MC programs Geant4 + PenEasy BEAMnrc + PenEasy PenEasy_PRIMO
LINAC ONCOR PRIMUS CLINAC 2300
RT treatment H&N mArc Prostate static IMRT Lung SBRT
Simulation # 1 2 1 2 1 2
Number of Workers 200 400 200 400 200 400
1st Worker SUT 8.1 5.6 6.4 7.9 5.9 5.9
Last Worker SUT 10.7 9.7 8.8 9.9 12.8 11.5
Workers mean time 6.8 ± 0.9 12.0 ± 1.9 3.5 ± 0.7 5.5 ± 1.4 7.7 ± 0.4 11.4 ± 0.8
Reducer merge time 1.3 2.4 1 1.9 3.1 8.3
Reducer upload time 1.2 1.2 0.4 0.7 0.9 1.25
Total simulation time 21.1 28.3 14.5 20.2 23.2 33.4
Uncertainty (k = 2) 3.6% 1.7% 2.9% 1.4% 3.8% 1.9%
Estimated cost (€) 4.3 15.7 2.6 7.4 5.5 13.6
SUT Start-up Time. All time measurements are given in minutes
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a Worker Roles service is created in Azure, VMs have to
be created over physical hardware and the operating sys-
tem needs to be initialized. This may take some minutes.
In Table 2 the SUT of the first and last Worker Roles is
presented. It seems that there is no correlation between
the number of Workers and the SUT of the first one or
the time interval between the first and the last Worker ini-
tialized. The SUT contribution to the total simulation time
might be removed if the Worker Roles service was already
created before starting the simulation, but it would in-
crease the final cost considerably.
The costs associated to MC verifications like those
presented above have a strong dependency on several
factors like the efficiency of the MC engine, the uncer-
tainty level desired, the features of the VMs used, etc. It
is important to point out that, since the release of the
first commercial clouds, important upgrades have been
made to provide more types of VMs optimized to per-
form different tasks, at the same time that the costs have
been decreasing more and more. For example, at the
time we published our previous work [19] in 2013, a lit-
tle variety of VMs sizes was available and their cost was
almost double as of today.
The results presented for the MC verification cases
should not be understood as a comparison of the effi-
ciency between different codes. There are many factors
that influence the calculation times, like the simulation
parameters (cutoff energies, variance reduction tech-
niques…), the dimensions and voxel size of the patient
voxelized phantom, etc. A more detailed study of the ef-
fect of these factors on the total simulation time could
be done in order to minimize times and costs, but it is
beyond the purpose of this work. Therefore, the aim of
using different MC codes was not to make a comparison
between them, but to show the flexibility of CloudMC.
In contrast to other initiatives that developed a highly
integrated solution pursuing near real-time MC calcula-
tions in a TPS [37], CloudMC has been designed as a
flexible platform independent of any commercial plan-
ning software that, at the same time, allows for the pos-
sibility of experimenting with different MC engines
independently of the code they are based on.
Regarding the implementation of PRIMO in CloudMC,
a new version of the PRIMO (version 0.3.1) has been re-
cently released that incorporates new features and sub-
stantial changes like, for example, the possibility of using
the fast MC code DPM [38] as the backend program to
run the simulations. The implementation of the new
PRIMO version in CloudMC has not been addressed yet,
but it is part of our project roadmap.
Conclusions
Following the path started in our previous work [19], the
MC verification of RT treatments has been implemented
in CloudMC. MC cloud-based solutions like the one
presented here overcome the main drawbacks historic-
ally associated to the use of MC algorithms in clinical
routine, as they take the main advantages from Cloud
Computing technology, which are high computational
power, scalability of the computational resources, easy
access and pay-per-usage model. The results achieved
prove Cloud Computing technology to be one of the
most promising solutions to solve finally the long-lived
problem of truly introducing the MC algorithms in the
daily routine of the RT planning process.
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